UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): July 6, 2004
PAINCARE HOLDINGS, INC.
(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)
FLORIDA | 1-14160 | (06-1110906) | ||
(STATE OR OTHER JURISDICTION OF INCORPORATION OR ORGANIZATION) | (COMMISSION FILE NUMBER) |
(IRS EMPLOYER IDENTIFICATION NUMBER) |
37 N. ORANGE AVENUE, SUITE 500
ORLANDO, FLORIDA 32801
(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES INCLUDING ZIP CODE)
(407) 926-6615
(REGISTRANTS TELEPHONE NUMBER, INCLUDING AREA CODE)
(407) 926-6616
(REGISTRANTS FACSIMILE NUMBER, INCLUDING AREA CODE)
WWW.PAINCAREINC.COM
(REGISTRANTS WEBSITE ADDRESS)
ITEM 7. Financial Statements and Exhibits
(a) | Not Applicable |
(b) | Not Applicable |
(c) | Exhibits. |
99.1 | Press release of the Company dated July 7, 2004. |
The exhibit attached hereto under Item 7. Financial Statements and Exhibits shall not be deemed filed for purposes of Section 18 of the Securities act of 1934.
ITEM 9. Regulation FD Disclosure
On July 7, 2004, the Company announced that Robert M. Wasserman, Director of Research at Dawson James Securities (DJS), a division of Viewtrade Financial, has published a report stating that DJS is initiating coverage on PainCare Holdings with a BUY rating and a 12-18 month price target of $5-$6, based on average price/earnings multiples of surgery center, physical therapy, and physician practice management companies.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
PAINCARE HOLDINGS, INC. | ||||
Date: July 7, 2004 |
BY: |
/s/ RANDY LUBINSKY | ||
Chief Executive Officer and Director | ||||
Date: July 7, 2004 |
BY: |
/s/ MARK SZPORKA | ||
Chief Financial Officer, Secretary and Director |